P6 treatment significantly enhanced BDNF mRNA levels (Fig. 6G; autism serum vs. autism serum+P6 group, Bonferroni’s post-hoc test, p>0.05, Student’s t-test, p = 0.0049). Here, BDNF is linked to autism.